Autolus Therapeutics' Series C Round

Autolus Therapeutics raised a round of funding on September 26, 2017.

Autolus is a biopharmaceutical company that is focused on the development and commercialization of engineered T-cell immunotherapy products to combat cancer. The company has a pipeline of products in …

Articles about Autolus Therapeutics' Series C Round: